Schematic computational workflow: The SVM predictor was initially developed using a bootstrapping procedure on n=44 primary SQCLC and n=30 HNSCC cases. An independent set of n=38 tumours was used for validation, before we applied the classifier to n=51 lung tumours of unknown origin. Survival analysis was used to assess classification performance on this final data set. 